Antitumor Combination comprising ombrabulin and cetuximab, Associated with radiotherapy

摘要

Antitumor agent for patients treated by radiotherapy, especially suffered from cancers and even more particularly targeted for solid tumors.Claim 1: pharmaceutical Combination comprising ombrabulin or AVE8062 in base form or in the form of a pharmaceutically acceptable Salt and cetuximab for use as an antitumor agent for patients treated by radiotherapy.